Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor.
Standard
Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor. / Marx, G; Nashan, Björn; Cobas Meyer, M; Vangerow, B; Schlitt, H J; Ziesing, S; Leuwer, M; Piepenbrock, S; Rueckoldt, H.
In: INTENS CARE MED, Vol. 25, No. 9, 9, 1999, p. 1017-1020.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor.
AU - Marx, G
AU - Nashan, Björn
AU - Cobas Meyer, M
AU - Vangerow, B
AU - Schlitt, H J
AU - Ziesing, S
AU - Leuwer, M
AU - Piepenbrock, S
AU - Rueckoldt, H
PY - 1999
Y1 - 1999
N2 - The extent of complement and contact activation is related to outcome in sepsis. A low functional index of their main blocker C1-esterase inhibitor (C1-INH) is considered as a relative deficiency of C1-INH and might contribute to the development of fatal complications in the intensive care unit. The first results of therapeutic intervention with C1-INH concentrate in septic shock are promising. We report on our experience of C1-INH concentrate administration in a young woman with Caroli's disease as ultimate rescue therapy for septic shock with capillary leakage syndrome after combined liver and kidney transplantation. No focus of infection was detectable and thus surgical intervention was not indicated. Antibiotic therapy at that time included vancomycin, tobramycin, meropenem and fluconazol. Hemodynamic stabilization occurred within hours after administration of C1-INH concentrate. Simultaneously a reduction in vasopressor medication was possible and negative fluid balance was achieved.
AB - The extent of complement and contact activation is related to outcome in sepsis. A low functional index of their main blocker C1-esterase inhibitor (C1-INH) is considered as a relative deficiency of C1-INH and might contribute to the development of fatal complications in the intensive care unit. The first results of therapeutic intervention with C1-INH concentrate in septic shock are promising. We report on our experience of C1-INH concentrate administration in a young woman with Caroli's disease as ultimate rescue therapy for septic shock with capillary leakage syndrome after combined liver and kidney transplantation. No focus of infection was detectable and thus surgical intervention was not indicated. Antibiotic therapy at that time included vancomycin, tobramycin, meropenem and fluconazol. Hemodynamic stabilization occurred within hours after administration of C1-INH concentrate. Simultaneously a reduction in vasopressor medication was possible and negative fluid balance was achieved.
M3 - SCORING: Zeitschriftenaufsatz
VL - 25
SP - 1017
EP - 1020
JO - INTENS CARE MED
JF - INTENS CARE MED
SN - 0342-4642
IS - 9
M1 - 9
ER -
